## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

||Note|2023||2022||
|---|---|---|---|---|---|
|Fixed Assets:||||||
|Investments||||||
|General Fund||4,755,134||5,041,345||
|Endowment<br>Funds —Expendable||76,650||82,086||
|Endowment<br>funds - Permanent||43,753||46,680||
|Restricted Funds||48,900||52,991||
||||4,924,437||5,223,102|
|Current Assets:||||||
|Cash atbank:||||||
|Current account||135,462||74,067||
|Deposit accounts||98,893||98,695||
|||234,355||172,762||
|Current Liabilities||||||
|Amounts<br>falling due within one year||43,684||69,205||
|Net Current Assets|||190,671||103,557|
|Net Assets|||5,115,108||5,326,659|
|Funds:||||||
|Unrestricted<br>Funds|||4,899,253||5,102,251|
|Restricted Funds|||72,120||75,273|
|Endowment<br>Funds - Expendable|||93,807||96,668|
|Endowment<br>Funds - Permanent|||49,928||52,467|
||||5,115,108||6 326669|





## 

## 

|||||Endowment|Endowment|Total|Total|
|---|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Expendable|Permanent|||
|||Funds|Funds|Funds|Funds|2023|2022|
||||||||f|
|Income and Endowments|from|||||||
|Stocks and shares||135,410|1,936|2,572|1,386|141,304|138,917|
|Deposit interest||152|2|3|2|159|13|
|Donations||||||0|60|
|Other Income||200||||200|0|
|||135,762|1,938|2,575|1,388|141.,663|138,990|
|Expenditure<br>on||||||||
|Charitable<br>activities|(Note 10)|(52,549)|(1,000)||(1,000)|(54,549)|(143,875)|
|Generating<br>funds||||||||
|Investment<br>management|charges||||||2,132|
|Net gains/(losses)<br>on investments||(286,211)|(4,091)|(5,436)|(2,927)|(298,665)|129,446|
|Net Income/(expenditure)||(202,998)|(3,153)|(2,861)|(2,539)|(211,551)|126,693|
|Other gains/losses||||||||
|Net Movement<br>in Funds||(202,998)|(3,153)|(2,861)|(2,539)|(211,551)|126,693|
|Fund balances brought|forward|5,102,251|75,273|96,668|52,467|5,326,659|5,199,966|
|Fund balances carried|forward|4,899/53|72,120|93,807|49,928|5,115,108|5,326,659|





## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

|Quoted Investments||||Trust|Pool||Trust|Trust|
|---|---|---|---|---|---|---|---|---|
||||Apportioned||Between||Pool|Pool|
||||||Endowment||Total|Total|
|||Unrestricted|Restricted||Expendable|Permanent|||
|||Funds|Funds||Funds|Funds|2023|2022|
|Market Value at31March 2022||5,041,345|52,991||82,086|46,680|5,223,102|5021437|
|Add: Additions at cost||||||||5,230,618|
|Less:Disposals||||||||(5,158,399)|
|Gain/(Loss) on revaluation||(286,211)|(4,091)||(5,436)|(2,927)|(298,665)|129,446|
|Market Value at31March 2023||4755 134|48|900|76,650|43 753|4,924,437|5,223 102|
|The Sarasin Endowments|Fund Class AIncome units were invested as follows.||||||||
|Equities|||||||3,258,299|3,634,483|
|Fixed income|||||||731,706|365,060|
|Properly|||||||218,061|290,862|
|Alternative<br>investments|||||||609,465|661,711|
|Liquid assets|||||||106,906|270,986|
||||||||4924437|5223 102|
|Historic Cost at31March 2022|||||||5241 166|5,230,618|





## 

## 

|||||2023||2022|
|---|---|---|---|---|---|---|
|3.Current Liabilities|||||||
|Grants and awards||||42,160||66,130|
|Professional fees||||1,524||1,425|
|Salary ofsecretary||||||1,650|
|||||43,684||69,205|
|4.Unrestricted<br>Funds|||||||
|Balance at 1April 2022||||5,102,251||4,985,507|
|Net surplus for the year||||(202,998)||116,744|
|Balance at31March 2022||||4,899,253||5,102/51|
|5.Restricted Funds|||||||
|||Balance||Loss on|||
|||1April 2022|Income|Revaluation|Expenditure|31Mar 2023|
|Theatres (Biomet) Fund||2,353||||2,353|
|John Spivey Prize||72,920|1,938|(4,091)|(1,000)|69,767|
|||75 273|1,938|4,091|1,000|72 120|
|6.Expendable<br>Endowment|Funds||||||
|||Balance||Loss on|Expenditure|Balance|
|FUND||1April 2022|Income|Revaluation||31Mar 2023|
|John Goodfellow Prize||36,381|962|(2,031)||35,312|
|David Fuller Memorial||16,018|424|(896)||15,546|
|Girdlestone<br>Society-R BDuthie Fund||44,269|1,189|(2,509)||42,949|
|||96,668|2,575|(5,436)||93,807|





|7.Permanent|Endowment|Endowment|Funds||||||
|---|---|---|---|---|---|---|---|---|
|Capital|||||Balance|Loss on|Expenditare|Balaace|
||||||1April 2022|Revaiaation||31Mar 2023|
|James Turner|Prize||||41,878|(2,927)||38,951|
||||||41,878|2,927||38,951|
|Income|||||||||
|||||||Income|Expenditam|Balance|
||||||1April 2022|||31Mar2023|
|||||||||f|
|James Turner|Prize||||10,589|1,388|(1,000)|10,977|
||||||10489|1388|(1,000|10,977|
|||||||2023||2022|
|Total ofPermanent||Endowment||Funds at31March 2023||49,928||52,467|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|||||||||
|---|---|---|---|---|---|---|---|
|9.Analysis ofCharitable Expenditure|||||2023||2022|
|Grants and awards (note 10)|||||42,660||132,760|
|Other charitable<br>expenditure|(note 11)||||9,889||10,115|
||||||52,549||142,875|
|10.Grants and Awards||||||||
||||||2023||2022|
|Lord Nuffield Scholarship<br>in|orthopaedic||surgery||||32,875|
|Girdlestone<br>Memorial scholarship<br>in||orthopaedic||surgery|||32,875|
|Research grants|||||||32,350|
|Total orthopaedic<br>scholarships|||||||98,100|
|Kenwright<br>Prize||||||500|500|
|Lord Nuffield scholarship<br>in aftercare||||||||
|Feilden nursing<br>scholarship||||||||
|Elizabeth Handfield<br>Jones travelling||scholarship||||||
|Girdlestone<br>Memorial nursing|scholarship|||||||
|Course, conference and travel|grants|||||||
|Nuffield Dept. ofOrthopaedic|Surgery research|||assistant|42,160||31,160|
|Grant forjournals and professional<br>publications|||||||3,000|
|Joseph Trueta prize||||||||
|Grants and Awards from Unrestricted|||Funds||42,660||132,760|
|Total Grants and Awards for the year||||||||
|Unrestricted<br>fund||||Note 9|52,549||142,875|
|Endowment<br>funds - Expendable|||||1,000|||
|Permanent||||||||
|Restricted funds|||||1,000||1,000|
||||||54 549||143,875|





## 

## 

||||2023|2022|
|---|---|---|---|---|
||||f|f|
|Trustees meetings|||||
|Salary ofsecretary|||8,050|8,140|
|Audit/Independent|examination|fee|1,551|1,425|
|Office expenses|||288|550|
||||9,889|10,115|



## 

## 

|13.Staff Costs|||
|---|---|---|
||2023|2022|
|Salaries|8,050|8,140|
|National insurance costs|||
||s 050|8,140|
|The Trust has one part-time employee.|||



|14.Ana|lysis ofAssets and L|iabilities||||||
|---|---|---|---|---|---|---|---|
|||||Endosrment||||
|||Unrestricted|Restricted|Expendable|Permanent|Total|Total|
|||Funds|Funds|Fuuds|Funds|2O23|2022|
|||||||f|f|
|Inveslments||4,755,134|48,900|76,650|43,753|4,924,437|5,223,102|
|Current|assets|187,803|23,220|17,157|6,175|234,355|172,762|
|Current|liabilities|(43,684)||||(43,684)|(69,205)|
|||4,899,253|72,120|93,807|49928|5 115108|5,326659|





## 

## 

||||Unrestricted|Restricted|Endowment|Funds|Total|
|---|---|---|---|---|---|---|---|
||||Funds|Funds|Expendable|Permanent|2022|
|Income and Endowments||from||||||
|Stocks and shares|||133250|1,875|2,458|1,334|138,917|
|Deposit|interest||12||1||13|
|Donations|||60||||60|
|Total Income|and Endowments|||1,875|2,459|1,334|138,990|
|Expenditure|on|||||||
|Charitable|activities||(142,875)|(1,000)|||(143,875)|
|Generating|funds|||||||
|Investment|management||2,132||||2,132|
|Net gains/(losses)<br>on investments|||124,165|1,747.00|2,291|1,243|129,446|
|Net Income/(expenditure)|||126,297|875|4,750|2,577|126,693|
|Other gains/losses||||||||
|Net Movement|in Funds||126,297|875|4,750|2,577|126,693|